Look for Drugs and Conditions

Participants at Aventor Biopharma forum discussions

Biopharma Forums Drive Collaboration and Innovation in India

Avantor, a global leader in providing essential products and services to the life sciences and advanced technology industries, recently organised a series of biopharmaceutical forums across India. These forums, held in Bengaluru, Hyderabad, and Pune, aimed to tackle the challenges faced by biopharmaceutical companies in the country through collaboration and technological innovation.

India's biopharmaceutical industry is growing rapidly, fueled by increased investments in research and development, robust product pipelines, and collaborations. However, challenges like evolving regulatory compliance and price and quality control hinder global competitiveness. The 2024 Avantor Biopharma Forums focused on critical topics such as scale-up, risk mitigation, and cost optimisation to address these challenges and drive industry growth.

With over 600 professionals from leading biopharmaceutical companies participating, the forums provided a platform for knowledge exchange and collaboration. Industry experts discussed biologics manufacturing, overcoming process challenges, and digital advancements in the industry.

Dr. Ger Brophy, Chairman of Avantor’s Scientific Advisory Board, highlighted the changing regulatory environment and readiness for adapting to evolving biological molecules. Mr. Narayana Rao Rapolu, VP, Biopharma and Applied Products Solutions, underscored the rise of the Indian biopharma sector and Avantor's innovative strategies to tackle industry challenges.

Dr. Nandkumar Deorkar, SVP Research and Development at Avantor, shared insights on effective Total Cost of Ownership management in bioprocessing. He emphasised Avantor's commitment to simplifying scale-up processes, driving cost optimisation, and improving biologics process efficiencies through strategic partnerships with biomanufacturers.

The Avantor Biopharma forums facilitated meaningful dialogue and exchange within the industry, with participants appreciating the knowledge-sharing sessions and engaging conversations. Avantor, a Fortune 500 company, is dedicated to enabling breakthroughs in medicine, healthcare, and technology globally.

From discovery to delivery, Avantor collaborates with scientists worldwide to support research, development, and production activities across 180 countries. Overall, the Avantor Biopharma forums exemplified the importance of collaboration and technological advancements in addressing challenges and driving growth in the Indian biopharma industry.


0 Comments
Be first to post your comments

Post your comment

Related Articles

Ad 5